BBVA
CDTX

Banco Bilbao Vizcaya Argentaria’s Cidara Therapeutics CDTX Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,389
Closed -$323K – 691
2020
Q2 		$323K Hold
4,389
– – 0.01% 616
2020
Q1 		$217K Buy
4,389
+1,389
+46% +$83.2K 0.01% 616
2019
Q4 		$230K Buy
+3,000
New +$137K 0.01% 663

Other funds holding CDTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's CDTX Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Cidara Therapeutics (CDTX) in Q3 2020, closing a stake of 4,389 shares — an estimated $323K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in CDTX in Q4 2019 and held it in 3 quarters. The position peaked at $323K in Q2 2020. 66 funds tracked by Wall St. Rank hold CDTX as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Cidara Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 4,389 Cidara Therapeutics shares in Q3 2020, an estimated $323K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Cidara Therapeutics in Q4 2019 and held it in 3 quarters.
  • Banco Bilbao Vizcaya Argentaria's Cidara Therapeutics position peaked at $323K in Q2 2020.
  • 66 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.